Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01031069
Recruitment Status : Unknown
Verified December 2016 by GlaxoSmithKline.
Recruitment status was:  Active, not recruiting
First Posted : December 14, 2009
Last Update Posted : December 16, 2016
Information provided by (Responsible Party):

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Unknown
  Actual Primary Completion Date : January 2016
  Estimated Study Completion Date : May 2017

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 January 13, 2017
(Canceled - Date Unknown)
January 16, 2017
(Canceled - Date Unknown)
January 26, 2017
(Canceled - Date Unknown)
February 2, 2017
(Canceled - Date Unknown)
February 13, 2017
March 30, 2017
2 April 13, 2017
(Canceled - Date Unknown)
April 14, 2017
(Canceled - Date Unknown)
April 20, 2017
(Canceled - Date Unknown)
July 25, 2017
(Canceled - Date Unknown)
December 22, 2017
(Canceled - Date Unknown)